# Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non–Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-efficacy-and-patient-reported-health-related-quality-of-life-and-symptom/

## Facts

| Field | Value |
| --- | --- |
| Author Names | David R. Spigel,Michael McCleod,Robert M. Jotte,Lawrence H. Einhorn,Leora Horn,David Waterhouse,Ben Creelan,Sunil Babu,Natasha B. Leighl,Jason C. Chandler,Félix Couture,George P. Keogh,Glenwood Goss,Davey B. Daniel,Edward B. Garon,Lee S. Schwartzberg,Rohini Sen,Beata Korytowsky,Ang Li,Nivedita Aanur,Maen Hussein |
| Citations | 188 |
| DOI | 10.1016/j.jtho.2019.05.010 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2946456966 |
| PMID | 31121324 |
| Type | article |
| Year | 2019 |

## Paper authors

- [David R. Spigel](https://scholariq.org/researchers/david-r-spigel/)
- [Ben Creelan](https://scholariq.org/researchers/ben-creelan/)
- [Edward B. Garon](https://scholariq.org/researchers/edward-b-garon/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.